Sandesh Seth

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ATNM

Current role

CEO, Board Member

2024-11-27–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Actinium Pharmaceuticals, Inc. (ATNM)	Chairman and Chief Executive Officer	$733,200	$440,000	—	—	—	—	$1,173,200
2023	Actinium Pharmaceuticals, Inc. (ATNM)	Chairman and Chief Executive Officer	$705,000	$500,000	—	$3,499,999	—	—	$4,704,999
2022	Actinium Pharmaceuticals, Inc. (ATNM)	Chairman and Chief Executive Officer	$665,000	$480,000	—	$2,875,167	—	—	$4,020,167
2021	Actinium Pharmaceuticals, Inc. (ATNM)	Chairman and Chief Executive Officer	$615,000	$430,000	—	$1,290,323	—	—	$2,335,323
2020	Actinium Pharmaceuticals, Inc. (ATNM)	Chairman and Chief Executive Officer	$578,191	$315,000	—	$938,537	—	—	$1,831,728
2019	Actinium Pharmaceuticals, Inc. (ATNM)	Chairman and Chief Executive Officer Mark Berger\	$561,350	$300,000	—	$241,367	—	—	$1,102,717
2018	Actinium Pharmaceuticals, Inc. (ATNM)	Chairman and Chief Executive Officer	$545,000	$280,000	—	$549,253	—	—	$1,374,253

Earnings-call appearances and filed executive appointments or departures, newest first.